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Foot and Mouth Disease (FMD) 
Affects cattle, pigs, sheep, goats, etc.
Highly contagious, spreads rapidly
Decreases productivity 25-50%
Severe economic losses Billion U$S 
OIE FMD Outbreak map 
January 2008 to June 2010
















Total Bovine Heads: 317.000.000
Brazil: 190.000.000
Argentina: 50.000.000
Foot and Mouth Disease virus (FMDV) 
Picornaviridae family 
Non-enveloped
Spherical particles of ~30 nm diameter
Capsid proteins VP1, VP2, VP3, VP4
Single RNA chain ~ 8.5 Kb
Pathogen level 4







More than 65 subtypes
Each subtype 100s of strains 
Inactivated whole virus vaccines
Manufacturing options
Virus propagation








Differentiating infected from vaccinated
Non-purified vaccine
Antibodies against SP: Y
Antibodies against NSP: Y
Y Y Y Y Y Y Y
Antibody profile similar to an
infected animal
Differentiating infected from vaccinated
Purified vaccine
Antibodies against SP
Y Y Y Y Y Y Y
Differentiating infected from vaccinated
Y Y Y Y Y Y Y
Non-purified vaccine
Y Y Y Y Y Y Y
Purified vaccine
The animal will have same 
antibodies as an infected animal 
Can be differentiated 
Differentiating infected from vaccinated
Process flowsheet
BHK suspension




















Single (2 ml) and double (4 ml) dose
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Batch release trials (purity)
> 500 Million doses tested
136 batches (2006, 2007, 2008, 2009)
17 cows / batch at 0 and 60 dpv
n= 4624






















Negative by confirmatory 
assay (EITB)
Batch release trials (potency)
Batches for Argentina: 49 (2006), 42 (2007), 23 (2008), 22 
(2009)
17 cows /batch 
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No requirement  for Biosecurity Level 3
Universal for different strains and types
Can differentiate Infected from Vaccinated
No animal derived ingredients 















Public private partnership is key
Sustainable Funding 
EC Mercosur Biotech Platform  
■ European Comission sponsored programme to
promote Biotechnology in Mercosur
■ EC funded research projects for Public private 
Consortia formed by research groups from Uruguay, 
Brasil, Paraguay and Argentina
Title: Aplication of functional genomics and other biotechnology
tools to the development and control of vaccines to prevent foot-
and-mouth disease in cattle.
Aims:
Introduce new technologies in the development and control of 
foot-and-mouth disease vaccines
Establish a platform for training in biotechnologies relevant to the 
development and production of veterinary vaccines
Establish a regional multidisciplinary and multisectorial research
team
Biotecsur Project 
Dr. Osvaldo Podhajcer, Fund. Instituto Leloir, ARGENTINA
Biotecsur Project 
Consortium
Dr. Fernando A. Goldbaum, Inmunova, ARGENTINA
Dra. Maria T. Rovira, Fac. C. Veterinarias, PARAGUAY
Dra. M. Susana Levy, Biogénesis-Bagó, ARGENTINA
EC Partner: Dr. Arndt Benecke, Inst.Hautes Etudes Scientifiques, FRANCE
Dr. José A. Chabalgoity, Fac. de Medicina, URUGUAY (coordinator)
Dra. Leda Castilho, Univ. Rio de Janeiro, BRASIL
Research targets:
Analytical methods
In process control chromatography





Logistics: distances, regulatory authority permits, Customs
Biotecsur Project 
FMDV
Development of a chromatographic method
for analysis of  process samples
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